| Literature DB >> 26211666 |
Jin-Young Shin1,2,3,4, Il-Hee Yoon1,2,3,4, Jong-Hyung Lim1,2,3,4, Jun-Seop Shin1,2,3,4, Hye-Young Nam1,2,3,4, Yong-Hee Kim1,2,3,4, Hyoung-Soo Cho1,2,3,4, So-Hee Hong1,2,3,4, Jung-Sik Kim1,2,3,4, Won-Woo Lee1,4, Chung-Gyu Park1,2,3,4.
Abstract
Regulatory T cells (Tregs) are a specialized subpopulation of T cells that control the immune response and thereby maintain immune system homeostasis and tolerance to self-antigens. Many subsets of CD4(+) Tregs have been identified, including Foxp3(+), Tr1, Th3, and Foxp3neg iT(R)35 cells. In this study, we identified a new subset of CD4(+)VEGFR1(high) Tregs that have immunosuppressive capacity. CD4(+)VEGFR1high T cells, which constitute approximately 1.0% of CD4(+) T cells, are hyporesponsive to T-cell antigen receptor stimulation. Surface marker and FoxP3 expression analysis revealed that CD4(+)VEGFR1(high) T cells are distinct from known Tregs. CD4(+)VEGFR1(high) T cells suppressed the proliferation of CD4(+)CD25(-) T cell as efficiently as CD4(+)CD25(high) natural Tregs in a contact-independent manner. Furthermore, adoptive transfer of CD4(+)VEGFR1(+) T cells from wild type to RAG-2-deficient C57BL/6 mice inhibited effector T-cell-mediated inflammatory bowel disease. Thus, we report CD4(+) VEGFR1(high) T cells as a novel subset of Tregs that regulate the inflammatory response in the intestinal tract.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26211666 PMCID: PMC4579660 DOI: 10.1038/cmi.2015.71
Source DB: PubMed Journal: Cell Mol Immunol ISSN: 1672-7681 Impact factor: 11.530